Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride is Used for treating allergic rhinitis, respiratory allergies, nasal swelling, sinus congestion, and pressure in adults and children aged 12 and older. It was first introduced by Chattem Inc Dba Sanofi Consumer Healthcare in its drug Allegra-D 12 Hour Allergy And Congestion on Jan 24, 2011. Another drug containing Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride is Allegra-D 24 Hour Allergy And Congestion. 8 different companies have introduced drugs containing Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride.

Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Patents

Given below is the list of patents protecting Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Allegra-d 24 Hour Allergy And Congestion	US6613357	Osmotic device containing pseudoephedrine and an H1 antagonist	Dec 25, 2020 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6039974	Pharmaceutical composition for combination of piperidinoalkanol-decongestant	Jul 31, 2018 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	USRE39069	Multi-layered osmotic device	May 29, 2018 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6037353 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Sep 14, 2017 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US6037353 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Sep 14, 2017 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6037353	Method of providing an antihistaminic effect in a hepatically impaired patient	Mar 14, 2017 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US6037353	Method of providing an antihistaminic effect in a hepatically impaired patient	Mar 14, 2017 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US5855912 (Pediatric)	Pharmaceutical compositions for piperidinalkanol compounds	Aug 28, 2015 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6113942 (Pediatric)	Pharmaceutical composition for piperidinoalkanol compounds	Aug 28, 2015 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US5855912	Pharmaceutical compositions for piperidinalkanol compounds	Feb 28, 2015 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6113942	Pharmaceutical composition for piperidinoalkanol compounds	Feb 28, 2015 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US7135571 (Pediatric)	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	Nov 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US7138524 (Pediatric)	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	Nov 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US7138524 (Pediatric)	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	Nov 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US5578610 (Pediatric)	Piperidine derivatives	May 26, 2014 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US5578610 (Pediatric)	Piperidine derivatives	May 26, 2014 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US7135571	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	May 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US7138524	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	May 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US7138524	Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof	May 18, 2014 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US5578610	Piperidine derivatives	Nov 26, 2013 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US5578610	Piperidine derivatives	Nov 26, 2013 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6187791 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Nov 11, 2012 (Expired)	Chattem Sanofi
Allegra-d 12 Hour Allergy And Congestion	US6399632 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Nov 11, 2012 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US6187791 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Nov 11, 2012 (Expired)	Chattem Sanofi
Allegra-d 24 Hour Allergy And Congestion	US6399632 (Pediatric)	Method of providing an antihistaminic effect in a hepatically impaired patient	Nov 11, 2012 (Expired)	Chattem Sanofi

Add above patents to watchlist

Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride's Family Patents

Full family tree

Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride. The first generic version for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride was by Barr Laboratories Inc and was approved on Apr 14, 2005. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Apr 17, 2025.

Given below is the list of companies who have filed for Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.